Insulet Corporation makes the Omnipod, a tubeless insulin pump worn on the body and controlled by a smartphone. The company reports Q3 results on November 5, and it enters that moment carrying the most short interest in at least a year while options positioning has swung sharply in the opposite direction, toward calls rather than puts. Short interest has climbed to 8.2% of the free…
PODD put/call ratio spikes to 0.7668, 4.0 standard deviations above its 20-day mean of 0.3787—the most extreme defensive options positioning in 52 weeks, signaling a sharp reversal to heavy put buying after the August 5 earnings crash.
Key data as of 5 Nov 2026
Insulet Corporation makes the Omnipod, a tubeless insulin pump worn on the body and controlled by a smartphone. The company reports Q3 results on November 5, and it enters that moment carrying the most short interest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PODD — free to start on ORTEX.
Sign up for free →Open PODD on ORTEX